C1QTNF3 and metabolic dysfunction-associated steatotic liver disease: Further, CTRP3 has been shown to be a potent insulin sensitizer and inhibits inflammation (Peterson et al., 2010), indicating that CTRP3 could play a major role in metabolic diseases such as obesity, nonalcoholic fatty liver disease, and type 2 diabetes.